Gut Priming With Oral Bovine Colostrum for Preterm Neonates; Randomized Control Trial

Author(s):  
2012 ◽  
Vol 80 (6) ◽  
pp. 465-469 ◽  
Author(s):  
Jagdish Kumar ◽  
Amit Upadhyay ◽  
Ajeet Kumar Dwivedi ◽  
Sunil Gothwal ◽  
Vijay Jaiswal ◽  
...  

2018 ◽  
Vol 65 (2) ◽  
pp. 122-129 ◽  
Author(s):  
Somashekhar M Nimbalkar ◽  
Ankush K Khanna ◽  
Dipen V Patel ◽  
Archana S Nimbalkar ◽  
Ajay G Phatak

2021 ◽  
Author(s):  
Deepti Thandaveshwara ◽  
Shivangi Ganeshan ◽  
Srinivasa Murthy Doreswamy ◽  
Sushma Krishnegowda

Author(s):  
Thornton S. Mu ◽  
Alicia C. Prescott ◽  
Gayle D. Haischer-Rollo ◽  
James K. Aden ◽  
Jonathan B. Shapiro

Objective Umbilical cord blood (UCB) for admission laboratories is an approach to decrease anemia risk in very low birth weight (VLBW) neonates. We hypothesized that UCB use results in higher hemoglobin concentration [HgB] around 24 hours of life. Study Design A randomized control trial among VLBW infants whose admission laboratories were drawn from UCB (n = 39) or the infant (n = 41) in three U.S. military NICUs (clinicaltrials.gov#NCT02103296). Results No demographic differences were observed between groups. UCB infants had higher [HgB] at 12 to 24 hours of life (15.5 vs. 14.0 g/dL, p = 0.02). The median time to first transfusion was 17 days longer in the experimental group (p = 0.04), and at discharge, their number of donor exposures was lower (1.1 vs. 1.8, p = 0.04). Conclusion In the first 24 hours of life that is a period of higher risk for hemodynamic instability, UCB utilization for admission bloodwork in VLBW infants results in higher [HgB]. Key Points


Sign in / Sign up

Export Citation Format

Share Document